Ifosfamide-induced hyperpigmentation.
Yule
S M
SM
Pearson
A D
AD
Craft
A W
AW
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D007223:Infant; D008297:Male; D012509:Sarcoma / Q000188:drug therapy*; D013997:Time Factors
D005047:Etoposide; D007069:Ifosfamide